REGENERON PHARMACEUTICALS, INC. (REGN)
Nasdaq · Pharmaceutical Preparations · Inc. NY
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Large insider saleBassler Bonnie L (director) sold $1.2M of stock
- Large insider salePOON CHRISTINE A (director) sold $1.8M of stock
- Large insider salePOON CHRISTINE A (director) sold $1.3M of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-01 | RYAN ARTHUR F | director | S | 2 | 710.87 | $1,422 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 5 | 711.49 | $3,557 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 1 | 712.09 | $712 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 2 | 714.13 | $1,428 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 4 | 707.4 | $2,830 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 6 | 709.45 | $4,257 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 7 | 706.74 | $4,947 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 14 | 705.56 | $9,878 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 15 | 704.28 | $10,564 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 24 | 703.46 | $16,883 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 5 | 701.76 | $3,509 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 15 | 702.46 | $10,537 |
| 2026-04-01 | RYAN ARTHUR F | director | S | 13 | 776.62 | $10,096 |
| 2026-04-01 | RYAN ARTHUR F | director | S | 9 | 777.42 | $6,997 |
| 2026-04-01 | RYAN ARTHUR F | director | S | 4 | 778.24 | $3,113 |
| 2026-04-01 | RYAN ARTHUR F | director | S | 40 | 779.71 | $31,188 |
| 2026-04-01 | RYAN ARTHUR F | director | S | 14 | 775.58 | $10,858 |
| 2026-04-01 | RYAN ARTHUR F | director | S | 8 | 773.59 | $6,189 |
| 2026-04-01 | RYAN ARTHUR F | director | S | 3 | 772.76 | $2,318 |
| 2026-04-01 | RYAN ARTHUR F | director | S | 1 | 771.32 | $771 |
| 2026-04-01 | RYAN ARTHUR F | director | S | 8 | 774.58 | $6,197 |
| 2026-03-02 | RYAN ARTHUR F | director | S | 20 | 789.28 | $15,786 |
| 2026-03-02 | RYAN ARTHUR F | director | S | 20 | 788.96 | $15,779 |
| 2026-03-02 | RYAN ARTHUR F | director | S | 2 | 787.34 | $1,575 |
| 2026-03-02 | RYAN ARTHUR F | director | S | 7 | 786.61 | $5,506 |
| 2026-03-02 | RYAN ARTHUR F | director | S | 11 | 785.48 | $8,640 |
| 2026-03-02 | RYAN ARTHUR F | director | S | 2 | 781.21 | $1,562 |
| 2026-03-02 | RYAN ARTHUR F | director | S | 10 | 783.62 | $7,836 |
| 2026-03-02 | RYAN ARTHUR F | director | S | 2 | 782.62 | $1,565 |
| 2026-03-02 | RYAN ARTHUR F | director | S | 7 | 777.46 | $5,442 |
| 2026-03-02 | RYAN ARTHUR F | director | S | 2 | 778.3 | $1,557 |
| 2026-03-02 | RYAN ARTHUR F | director | S | 5 | 779.69 | $3,898 |
| 2026-03-02 | RYAN ARTHUR F | director | S | 3 | 780.69 | $2,342 |
| 2026-03-02 | RYAN ARTHUR F | director | S | 9 | 784.48 | $7,060 |
| 2026-02-19 | Zoghbi Huda Y | director | S | 4 | 790 | $3,160 |
| 2026-02-19 | Zoghbi Huda Y | director | S | 160 | 784.45 | $125,512 |
| 2026-02-19 | Zoghbi Huda Y | director | M | 1,638 | 376.69 | $617,018 |
| 2026-02-19 | Zoghbi Huda Y | director | S | 56 | 785.61 | $43,994 |
| 2026-02-19 | Zoghbi Huda Y | director | S | 49 | 774.68 | $37,959 |
| 2026-02-19 | Zoghbi Huda Y | director | S | 220 | 783.29 | $172,324 |
| 2026-02-19 | Zoghbi Huda Y | director | S | 298 | 782.1 | $233,066 |
| 2026-02-19 | Zoghbi Huda Y | director | S | 209 | 781.28 | $163,288 |
| 2026-02-19 | Zoghbi Huda Y | director | S | 331 | 780.45 | $258,329 |
| 2026-02-19 | Zoghbi Huda Y | director | S | 208 | 779.55 | $162,146 |
| 2026-02-19 | Zoghbi Huda Y | director | S | 53 | 778.47 | $41,259 |
| 2026-02-19 | Zoghbi Huda Y | director | S | 50 | 775.5 | $38,775 |
| 2026-02-09 | Pitofsky Jason | officer | S | 521 | 776.43 | $404,520 |
| 2026-02-09 | Pitofsky Jason | officer | S | 53 | 785.72 | $41,643 |
| 2026-02-09 | Pitofsky Jason | officer | S | 1 | 784.66 | $785 |
| 2026-02-09 | Pitofsky Jason | officer | S | 144 | 783.23 | $112,785 |
Federal contracts
24-month federal obligations: $-766,396
- 2026-09-16 $-766,396 · Department of Health and Human Services · DE-OBLIGATE CANCELING FUNDS ON OPTION 2, EXTEND POP FOR CLINS 0002 AND 0003 TO SEPT 25, 2027, ADD FINAL INDIRECT RATES A
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
7-day average 171 views/day vs 90-day median 193.